These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
706 related items for PubMed ID: 30761824
21. Antimicrobial susceptibility of gram-negative bacilli isolated from intra-abdominal and urinary-tract infections in Mexico from 2009 to 2015: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART). Ponce-de-Leon A, Rodríguez-Noriega E, Morfín-Otero R, Cornejo-Juárez DP, Tinoco JC, Martínez-Gamboa A, Gaona-Tapia CJ, Guerrero-Almeida ML, Martin-Onraët A, Vallejo Cervantes JL, Sifuentes-Osornio J. PLoS One; 2018; 13(6):e0198621. PubMed ID: 29927958 [Abstract] [Full Text] [Related]
22. Carbapenem susceptibilities of Gram-negative pathogens in intra-abdominal and urinary tract infections: updated report of SMART 2015 in China. Zhang H, Kong H, Yu Y, Wu A, Duan Q, Jiang X, Zhang S, Sun Z, Ni Y, Wang W, Wang Y, Liao K, Li H, Yang C, Huang W, Gui B, Shan B, Badal R, Yang Q, Xu Y. BMC Infect Dis; 2018 Sep 29; 18(1):493. PubMed ID: 30268102 [Abstract] [Full Text] [Related]
23. Ceftolozane/tazobactam activity tested against aerobic Gram-negative organisms isolated from intra-abdominal and urinary tract infections in European and United States hospitals (2012). Sader HS, Farrell DJ, Flamm RK, Jones RN. J Infect; 2014 Sep 29; 69(3):266-77. PubMed ID: 24780763 [Abstract] [Full Text] [Related]
24. Extended-spectrum beta-lactamases in urinary isolates of Escherichia coli, Klebsiella pneumoniae and other gram-negative bacteria in a hospital in Eastern Province, Saudi Arabia. Kader AA, Angamuthu K. Saudi Med J; 2005 Jun 29; 26(6):956-9. PubMed ID: 15983682 [Abstract] [Full Text] [Related]
25. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study]. Gür D, Gülay Z, Akan OA, Aktaş Z, Kayacan CB, Cakici O, Eraç B, Gültekin M, Oğünç D, Söyletir G, Unal N, Uysal S. Mikrobiyol Bul; 2008 Oct 29; 42(4):537-44. PubMed ID: 19149074 [Abstract] [Full Text] [Related]
26. Antimicrobial susceptibility of Gram-negative bacteria causing intra-abdominal infections in China: SMART China 2011. Zhang H, Yang Q, Xiao M, Chen M, Badal RE, Xu Y. Chin Med J (Engl); 2014 Oct 29; 127(13):2429-33. PubMed ID: 24985578 [Abstract] [Full Text] [Related]
27. Antimicrobial activity of ceftolozane-tazobactam against Enterobacterales and Pseudomonas aeruginosa recovered during the Study for Monitoring Antimicrobial Resistance Trends (SMART) program in Spain (2016-2018). Cantón R, Loza E, Arcay RM, Cercenado E, Castillo FJ, Cisterna R, Gálvez-Benítez L, González Romo F, Hernández-Cabezas A, Rodríguez-Lozano J, Suárez-Barrenechea AI, Tubau F, Díaz-Regañón J, López-Mendoza D, SMART-Spain Working Group. Rev Esp Quimioter; 2021 Jun 29; 34(3):228-237. PubMed ID: 33645948 [Abstract] [Full Text] [Related]
28. In vitro activity of imipenem-relebactam against resistant phenotypes of Enterobacteriaceae and Pseudomonas aeruginosa isolated from intraabdominal and urinary tract infection samples - SMART Surveillance Europe 2015-2017. Lob SH, Karlowsky JA, Young K, Motyl MR, Hawser S, Kothari ND, Sahm DF. J Med Microbiol; 2020 Feb 29; 69(2):207-217. PubMed ID: 31976856 [Abstract] [Full Text] [Related]
29. Antibiotic susceptibility patterns and trends of the gram-negative bacteria isolated from the patients in the emergency departments in China: results of SMART 2016-2019. Fu Y, Zhao F, Lin J, Li P, Yu Y. BMC Infect Dis; 2024 May 17; 24(1):501. PubMed ID: 38760687 [Abstract] [Full Text] [Related]
30. Molecular characterization of multidrug-resistant Gram-negative pathogens in three tertiary hospitals in Cairo, Egypt. El-Kholy AA, Girgis SA, Shetta MAF, Abdel-Hamid DH, Elmanakhly AR. Eur J Clin Microbiol Infect Dis; 2020 May 17; 39(5):987-992. PubMed ID: 31953591 [Abstract] [Full Text] [Related]
31. Epidemiology and antimicrobial susceptibility of Gram-negative aerobic bacteria causing intra-abdominal infections during 2010-2011. Hawser S, Hoban DJ, Badal RE, Bouchillon SK, Biedenbach D, Hackel M, Morrissey I. J Chemother; 2015 Feb 17; 27(2):67-73. PubMed ID: 24548089 [Abstract] [Full Text] [Related]
32. Occurrence of ESBL & Amp-C beta-lactamases & susceptibility to newer antimicrobial agents in complicated UTI. Taneja N, Rao P, Arora J, Dogra A. Indian J Med Res; 2008 Jan 17; 127(1):85-8. PubMed ID: 18316858 [Abstract] [Full Text] [Related]
33. Antimicrobial susceptibilities of specific syndromes created with organ-specific weighted incidence antibiograms (OSWIA) in patients with intra-abdominal infections. Liu L, Ni Y. BMC Infect Dis; 2018 Nov 19; 18(1):584. PubMed ID: 30453893 [Abstract] [Full Text] [Related]
34. Antimicrobial resistance comparison of Klebsiella pneumoniae pathogens isolated from intra-abdominal and urinary tract infections in different organs, hospital departments and regions of China between 2014 and 2017. Zhang H, Zhang G, Yang Y, Zhang J, Li D, Duan S, Yang Q, Xu Y. J Microbiol Immunol Infect; 2021 Aug 19; 54(4):639-648. PubMed ID: 32247662 [Abstract] [Full Text] [Related]
35. Epidemiology and genetic characteristics of extended-spectrum β-lactamase-producing Gram-negative bacteria causing urinary tract infections in long-term care facilities. Tinelli M, Cataldo MA, Mantengoli E, Cadeddu C, Cunietti E, Luzzaro F, Rossolini GM, Tacconelli E. J Antimicrob Chemother; 2012 Dec 19; 67(12):2982-7. PubMed ID: 22865381 [Abstract] [Full Text] [Related]
37. In vitro susceptibilities of aerobic and facultative anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections at a medical center in Taiwan: results of the Study for Monitoring Antimicrobial Resistance Trends (SMART) 2002-2006. Chen WY, Jang TN, Huang CH, Hsueh PR. J Microbiol Immunol Infect; 2009 Aug 19; 42(4):317-23. PubMed ID: 19949755 [Abstract] [Full Text] [Related]
38. Antimicrobial susceptibility of inpatient urinary tract isolates of gram-negative bacilli in the United States: results from the study for monitoring antimicrobial resistance trends (SMART) program: 2009-2011. Bouchillon SK, Badal RE, Hoban DJ, Hawser SP. Clin Ther; 2013 Jun 19; 35(6):872-7. PubMed ID: 23623624 [Abstract] [Full Text] [Related]
39. Increasing extended-spectrum beta-lactamase production and quinolone resistance among Gram-negative bacilli causing intra-abdominal infections in the Asia/Pacific region: data from the Smart Study 2002-2006. Ko WC, Hsueh PR. J Infect; 2009 Aug 19; 59(2):95-103. PubMed ID: 19564044 [Abstract] [Full Text] [Related]
40. Bacterial profile and patterns of antimicrobial drug resistance in intra-abdominal infections: current experience in a teaching hospital. Shree N, Arora BS, Mohil RS, Kasana D, Biswal I. Indian J Pathol Microbiol; 2013 Aug 19; 56(4):388-92. PubMed ID: 24441227 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]